← Back to Search

Gamified Exercise for Peripheral Artery Disease (GAMEPAD Trial)

N/A
Waitlist Available
Led By Alexander Fanaraff, MD, MHS
Research Sponsored by University of Pennsylvania
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 weeks
Awards & highlights

GAMEPAD Trial Summary

This trial will compare a Fitbit-based walking program with a gamified interface to a standard walking program in patients with intermittent claudication.

Who is the study for?
This trial is for adults over 18 with Peripheral Artery Disease (PAD), evidenced by specific medical tests or procedures. Participants must own a smartphone or tablet and not be in any supervised exercise program for PAD, have a life expectancy of more than 6 months, walk less than 7500 steps/day during baseline data collection, and cannot have critical limb issues or planned leg surgeries.Check my eligibility
What is being tested?
The study compares a standard home-based walking program with one enhanced by gamification techniques to encourage exercise in PAD patients. Participants will use Fitbits to track their activity and receive text reminders. Half will experience the gamified system designed using behavioral economics principles.See study design
What are the potential side effects?
Since this trial involves physical exercise augmented by digital tracking and motivational strategies rather than medication, side effects are minimal but may include typical risks associated with increased physical activity such as muscle strain or injury.

GAMEPAD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Secondary outcome measures
Change in daily step count
Other outcome measures
Change in PROMIS mobility, pain interference, and satisfaction with social roles and activities scores
Change in SF-36 physical functioning scale
Change in Walking Impairment Questionnaire score
+1 more

GAMEPAD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants have a 4-week ramp-up towards their step goal and are asked to maintain the goal for the rest of the study. They receive daily texts informing them if they met their step goal and biweekly texts to encourage walking for exercise. Participants are entered into a game. Each week they receive 70 points. If the step goal was met they keep their points. If not, they lose 10 points. At the end of the week if they have at least 40 points they move up a level. If not, they drop a level. Participants start in the middle of 5 levels. Participants choose a support partner who gets a weekly email with the participant's progress. We hold a 3-way phone call with the participant and partner to discuss ways they can help the participant meet their goal. Every 8 weeks, we have a follow up call if the participant is stuck in a lower level and restart them back at the middle level. In the follow-up period, participants continue to get a daily text stating if they met their step goal.
Group II: ControlActive Control1 Intervention
Via the Way to Health platform, all patients will receive daily text messages that inform them of their previous day's step count for 24 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Gamification and Social Incentives
2020
N/A
~110

Find a Location

Who is running the clinical trial?

University of PennsylvaniaLead Sponsor
2,000 Previous Clinical Trials
42,879,985 Total Patients Enrolled
5 Trials studying Peripheral Arterial Disease
1,299 Patients Enrolled for Peripheral Arterial Disease
Alexander Fanaraff, MD, MHSPrincipal InvestigatorUniversity of Pennsylvania
Alexander Fanaroff, MD, MHSPrincipal InvestigatorUniversity of Pennsylvania
5 Previous Clinical Trials
4,333 Total Patients Enrolled
1 Trials studying Peripheral Arterial Disease
1,200 Patients Enrolled for Peripheral Arterial Disease

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

To what extent has enrollment for this medical study been limited?

"Affirmative. According to the resources on clinicaltrials.gov, this study was initially posted on October 5th 2020 and is presently recruiting participants. A total of 100 individuals are needed across 1 medical centre for data collection purposes."

Answered by AI

Is there still capacity for subjects to join this research endeavor?

"According to clinicaltrials.gov, this trial has been open since October 5th 2020 and the most recent update was provided on September 30th 2022, hence participants are still being recruited for participation."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Gamification-Augmented Home-Based Exercise for Peripheral Artery Disease
2020. "Gamification-Augmented Home-Based Exercise for Peripheral Artery Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04536012.
~23 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top